Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (40)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Yin, Z.
Right arrow Articles by Sieper, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yin, Z.
Right arrow Articles by Sieper, J.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 1999; 38: 1058-1067
© 1999 British Society for Rheumatology

The elevated ratio of interferon gamma-/ interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta

Z. Yin1,2, S. Siegert1, L. Neure1,2, M. Grolms1, L. Liu2, U. Eggens1, A. Radbruch2, J. Braun1 and J. Sieper1,2

1 Department of Medicine, Division of Nephrology and Rheumatology, Klinikum Benjamin Franklin, Free University, Berlin and
2 Deutsches Rheuma Forschungszentrum Berlin, Berlin, Germany

Correspondence to: J. Sieper, Department of Medicine, Rheumatology, Klinikum Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany.

Objectives.To quantify the T-helper type (Th) 1 cytokine interferon gamma (IFN-{gamma})-positive and the Th2 cytokine interleukin (IL)-4-positive cells in synovial fluid (SF) and synovial membrane (SM) at the single-cell level in rheumatoid arthritis (RA) in comparison to reactive arthritis (ReA), and to manipulate the cytokine pattern of RA patients in vitro.

Methods.Eighteen patients with RA and 17 with ReA were studied. For intracellular staining of cytokines, SF mononuclear cells (MNC) from seven patients with RA, in comparison to eight patients with ReA, were triple stained with anti-IFN-{gamma}, IL-4 and anti-CD4 or anti-CD8 monoclonal antibodies (mAb) and analysed by flow cytometry. Furthermore, in 13 patients with RA, immunohistology of SM was performed and compared with seven ReA patients. In addition, in six of the RA patients, synovial T cells were grown over 3 weeks in the presence of various cytokines and intracellular cytokine staining analysed by flow cytometry weekly.

Results.In SF, the mean percentage of IFN-{gamma}+/CD4+ T cells in RA was almost 4-fold higher than the number of IL-4+/CD4+ T cells (11.3±5 vs 3.02±1.04; P=0.0012), while the ratio of IFN-{gamma}/IL-4+ CD4+ T cells was only 1.59 in ReA (P=0.047 for the ratio difference). A similar result was obtained for SM: the ratio of IFN-{gamma}/IL-4+ cells in RA was 4.3 (P<0.0001 for the IFN-{gamma}/IL-4 difference), but only 1.2 for ReA (P=0.02 for the ratio difference). Of the CD3+ cells in SM, 2.8% were positive for IFN-{gamma} and 0.4% for IL-4 in three RA patients. A decrease in the number of IFN-{gamma}-positive SF T cells and an increase in the number of IL-4-positive SF T cells could be achieved in vitro through IL-4, but not by IL-10 or transforming growth factor beta.

Conclusions.The Th1 pattern in the joint of RA patients demonstrated at the single-cell level may be important for the pathogenesis of RA and may provide a target for future immunotherapy. Our data suggest a therapeutic role for IL-4.

KEY WORDS: Th1 cytokines, Rheumatoid arthritis, Intracellular cytokines, Cytokine manipulation


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
BloodHome page
A. Sattler, U. Wagner, M. Rossol, J. Sieper, P. Wu, A. Krause, W. A. Schmidt, S. Radmer, S. Kohler, C. Romagnani, et al.
Cytokine-induced human IFN-{gamma}-secreting effector-memory Th cells in chronic autoimmune inflammation
Blood, February 26, 2009; 113(9): 1948 - 1956.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
F. Behrens, A. Himsel, S. Rehart, J. Stanczyk, B. Beutel, S. Y Zimmermann, U. Koehl, B. Moller, S. Gay, J. P Kaltwasser, et al.
Imbalance in distribution of functional autologous regulatory T cells in rheumatoid arthritis
Ann Rheum Dis, September 1, 2007; 66(9): 1151 - 1156.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Wang, Y. Gao, E. Scully, C. T. Davis, J. F. Anderson, T. Welte, M. Ledizet, R. Koski, J. A. Madri, A. Barrett, et al.
{gamma}{delta} T Cells Facilitate Adaptive Immunity against West Nile Virus Infection in Mice
J. Immunol., August 1, 2006; 177(3): 1825 - 1832.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
I. Butrimiene, S. Jarmalaite, J. Ranceva, A. Venalis, L. Jasiuleviciute, and A. Zvirbliene
Different cytokine profiles in patients with chronic and acute reactive arthritis
Rheumatology, October 1, 2004; 43(10): 1300 - 1304.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. Hanyuda, T. Kasama, T. Isozaki, M. M. Matsunawa, N. Yajima, H. Miyaoka, H. Uchida, Y. Kameoka, H. Ide, and M. Adachi
Activated leucocytes express and secrete macrophage inflammatory protein-1{alpha} upon interaction with synovial fibroblasts of rheumatoid arthritis via a {beta}2-integrin/ICAM-1 mechanism
Rheumatology, November 1, 2003; 42(11): 1390 - 1397.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
S. Bas, T. K. Kvien, N. Buchs, T. Fulpius, and C. Gabay
Lower level of synovial fluid interferon-{gamma} in HLA-B27-positive than in HLA-B27-negative patients with Chlamydia trachomatis reactive arthritis
Rheumatology, March 1, 2003; 42(3): 461 - 467.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
R. Gerli, C. Lunardi, and C. Pitzalis
Unmasking the anti-inflammatory cytokine response in rheumatoid synovitis
Rheumatology, December 1, 2002; 41(12): 1341 - 1345.
[Full Text] [PDF]


Home page
Ann Rheum DisHome page
J Braun, J Sieper, M Breban, E Collantes-Estevez, J Davis, R Inman, H Marzo-Ortega, and H Mielants
Anti-tumour necrosis factor {alpha} therapy for ankylosing spondylitis: international experience
Ann Rheum Dis, November 1, 2002; 61(90003): iii51 - 60.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
J Sibilia and F-X Limbach
Reactive arthritis or chronic infectious arthritis?
Ann Rheum Dis, July 1, 2002; 61(7): 580 - 587.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
D Baeten, N Van Damme, F Van den Bosch, E Kruithof, M De Vos, H Mielants, E M Veys, and F De Keyser
Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNF{alpha}
Ann Rheum Dis, August 1, 2001; 60(8): 750 - 755.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.